Antiviral and Anti-Inflammatory Therapeutic Interventions for Treating Herpes Stromal Keratitis: A Systematic Review

References

• Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57(5):448–462. doi:10.1016/j.survophthal.2012.01.005.
   PubMed Web of Science ®Google Scholar
• Lairson DR, Begley CE, Reynolds TF, et al. Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol. 2003;121(1):108–112. doi:10.1001/archopht.121.1.108.
   PubMedGoogle Scholar
• Al-Dujaili LJ, Clerkin PP, Clement C, et al. Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol. 2011;6(8):877–907. doi:10.2217/fmb.11.73.
   PubMed Web of Science ®Google Scholar
• Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res. 2006;25(4):355–380. doi:10.1016/j.preteyeres.2006.05.001.
   PubMed Web of Science ®Google Scholar
• Liesegang TJ. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107(8):1160–1165. doi:10.1001/archopht.1989.01070020226030.
   PubMedGoogle Scholar
• Miserocchi E, Waheed NK, Dios E, et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology. 2002;109(8):1532–1537. doi:10.1016/s0161-6420(02)01113-2.
   PubMed Web of Science ®Google Scholar
• Norn MS. Dendritic (herpetic) keratitis. I. Incidence–seasonal variations–recurrence rate–visual impairment–therapy. Acta Ophthalmol (Copenh). 1970;48(1):91–107. doi:10.1111/j.1755-3768.1970.tb06577.x.
   PubMedGoogle Scholar
• Valyi-Nagy T, Sheth V, Clement C, et al. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Curr Eye Res. 2004;29(4–5):303–309. doi:10.1080/02713680490516756.
   PubMed Web of Science ®Google Scholar
• McGill J. The enigma of herpes stromal disease. Br J Ophthalmol. 1987;71(2):118–125. doi:10.1136/bjo.71.2.118.
   PubMed Web of Science ®Google Scholar
• Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol. 2009;54(2):226–234. doi:10.1016/j.survophthal.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Steuhl KP. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study. Graefes Arch Clin Exp Ophthalmol. 1999;237(5):435–438. doi:10.1007/s004170050257.
   PubMed Web of Science ®Google Scholar
• Barker NH. Ocular herpes simplex. BMJ Clin Evid. 2008;2008:0707. Published 2008 Jul 23.
   PubMedGoogle Scholar
• Power WJ, Hillery MP, Benedict-Smith A, Collum LM. Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis. Br J Ophthalmol. 1992;76(12):711–713. doi:10.1136/bjo.76.12.711.
   PubMed Web of Science ®Google Scholar
• Poirier RH, Kingham JD, de Miranda P, Annel M. Intraocular antiviral penetration. Arch Ophthalmol. 1982;100(12):1964–1967. doi:10.1001/archopht.1982.01030040944016.
   PubMedGoogle Scholar
• Collum LM, Akhtar J, McGettrick P. Oral acyclovir in herpetic keratitis. Trans Ophthalmol Soc U K. 1985;104:629–632.
   PubMedGoogle Scholar
• Collum LM, McGettrick P, Akhtar J, Lavin J, Rees PJ. Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration. Br J Ophthalmol. 1986;70(6):435–438. doi:10.1136/bjo.70.6.435.
   PubMed Web of Science ®Google Scholar
• Hung SO, Patterson A, Rees PJ. Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol. 1984;68(3):192–195. doi:10.1136/bjo.68.3.192.
   PubMed Web of Science ®Google Scholar
• Robbins RM, Galin MA. A model for steroid effects in herpes keratitis. Arch Ophthalmol. 1975;93(9):828–830. doi:10.1001/archopht.1975.01010020716009.
   PubMedGoogle Scholar
• DAWSON C, TOGNI B, MOORE T, COLEMAN V. Herpes virus infection of human mesodermal tissue (Cornea) detected by electron microscopy. Nature. 1968;217(5127):460–462. doi:10.1038/217460b0.
   PubMed Web of Science ®Google Scholar
• Dawson CR, Jones DB, Kaufman HE, Barron BA, Hauck WW, Wilhelmus KR. Design and organization of the herpetic eye disease study (HEDS). Curr Eye Res. 1991;10(Suppl):105–110. doi:10.3109/02713689109020365.
   PubMedGoogle Scholar
• Rao SN. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol. 2006;141(4):771–772. doi:10.1016/j.ajo.2005.11.042.
   PubMed Web of Science ®Google Scholar
• Yoon KC, Heo H, Kang IS, et al. Effect of topical cyclosporin a on herpetic stromal keratitis in a mouse model. Cornea. 2008;27(4):454–460. doi:10.1097/ICO.0b013e318160602d.
   PubMed Web of Science ®Google Scholar
• Hendricks RL, Barfknecht CF, Schoenwald RD, Epstein RJ, Sugar J. The effect of flurbiprofen on herpes simplex virus type 1 stromal keratitis in mice. Invest Ophthalmol Vis Sci. 1990;31:1503–1511.
   PubMed Web of Science ®Google Scholar
• Zabawski EJ, Costner M, Cohen JB, Cockerell CJ. Tacrolimus: pharmacology and therapeutic uses in dermatology. Int J Dermatol. 2000;39(10):721–727. doi:10.1046/j.1365–4362.2000.00731.x.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea. 1999;18(2):144–154. doi:10.1097/00003226-199903000-00002.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Published 2019 Aug 28; 366:l4898. 10.1136/bmj.l4898
   PubMed Web of Science ®Google Scholar
• Collum LM, Logan P, Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis. Br J Ophthalmol. 1983;67(2):115–118. doi:10.1136/bjo.67.2.115.
   PubMed Web of Science ®Google Scholar
• Porter SM, Patterson A, Kho P. A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis. Br J Ophthalmol. 1990;74(5):283–285. doi:10.1136/bjo.74.5.283.
   PubMed Web of Science ®Google Scholar
• Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1871–1882. doi:10.1016/s0161-6420(13)31155-5.
   PubMed Web of Science ®Google Scholar
• Akbari M, Soltani Moghadam R, Elmi R, Nosrati A, Taghiabadi E, Aghdami N. Topical tacrolimus as an adjunct to conventional therapy for stromal herpetic keratitis: a randomized clinical trial. J Ophthalmic Vis Res. 2019;14(4):400–411. doi:10.18502/jovr.v14i4.5437.
   PubMed Web of Science ®Google Scholar
• Peyman A, Nayebzadeh M, Peyman M, Afshari NA, Pourazizi M. Topical cyclosporine-A versus prednisolone for herpetic stromal keratitis: a randomized controlled trial. Acta Ophthalmol. 2019;97(2):e194–198. doi:10.1111/aos.13913.
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1883–1896. doi:10.1016/s0161-6420(94)31087-6.
   PubMed Web of Science ®Google Scholar
• Vajpayee RB, Dhakal BP, Gupta SK, et al. Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis. Aust N Z J Ophthalmol. 1996;24(2):131–135. doi:10.1111/j.1442-9071.1996.tb01567.x.
   PubMedGoogle Scholar
• van Ganswijk R, Oosterhuis JA, Swart-van den Berg M, Versteeg J. Acyclovir treatment in stromal herpetic keratitis. Doc Ophthalmol. 1983;55(1–2):57–61. doi:10.1007/BF00140462.
   PubMed Web of Science ®Google Scholar
• Schwab IR. Oral acyclovir in the management of herpes simplex ocular infections. Ophthalmology. 1988;95(4):423–430. doi:10.1016/s0161-6420(88)33156-8.
   PubMed Web of Science ®Google Scholar
• Sanitato JJ, Asbell PA, Varnell ED, Kissling GE, Kaufman HE. Acyclovir in the treatment of herpetic stromal disease. Am J Ophthalmol. 1984;98(5):537–547. doi:10.1016/0002-9394(84)90237-x.
   PubMed Web of Science ®Google Scholar
• Patterson A, Jones BR. The management of ocular herpes. Trans Ophthalmol Soc U K. 1967;87:59–84.
   PubMedGoogle Scholar
• Sundmacher R. Trifluorthymidinprophylaxe bei der Steroidtherapie herpetischer Keratouveitiden [Trifluorothymidin-prophylaxis of dendritic keratitis in steroid-treated herpetic keratouveitis (author’s transl)]. Klin Monbl Augenheilkd. 1978;173:516–519.
   PubMedGoogle Scholar
• Gündüz K, Ozdemir O. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis. Ophthalmic Res. 1997;29(6):405–408. doi:10.1159/000268041.
   PubMed Web of Science ®Google Scholar
• Eriş E, Yüksel N, Pirhan D, et al. Evaluation of effect of topical tacrolimus treatment on herpetic stromal keratitis in a rat model. Eye Contact Lens. 2016;42(3):163–170. doi:10.1097/ICL.0000000000000162.
   PubMed Web of Science ®Google Scholar
• Liang L, Lin L, Liu Z. Efficacy of tacrolimus eyedrops topical application for herpes simplex disciform stromal keratitis and its influence on tear. Chin J Experimental Ophthalmol. 2015;33(1):60–65. doi:10.3760/cma.j.issn.2095-0160.2015.01.013.
   Google Scholar